RNA binding protein ELAVL1 is associated with severity and prognosis of hepatocellular carcinoma patients: A retrospective study
Higher serum levels of ELAVL1 are associated with worse clinical outcomes and poorer prognosis in ‑HCC patients.
Authors
- Longyun Chen (ORCID: https://orcid.org/0000-0002-5895-7580)
- Guibao Ji
- Zhuolin Li
- Jingyu Chen (ORCID: https://orcid.org/0000-0002-0563-9749)
- Qiuxia Guo (ORCID: https://orcid.org/0000-0002-6687-243X)
Institutions
- Tianjin Economic-Technological Development Area (CN)
- Wuhan Puai Hospital (CN)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2025-02-12
- DOI
- https://doi.org/10.17219/acem/195187
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00